Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(3-(2-(1-isopropyl-3-methyl-1h-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide
2. Gdc-0032
3. Gdc0032
4. Ro5537381
1. Gdc-0032
2. 1282512-48-4
3. 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide
4. Gdc 0032
5. Taselisib [inn]
6. Gdc0032
7. Taselisib (gdc0032)
8. Rg-7604
9. Rg7604
10. Chembl2387080
11. L08j2o299m
12. Rg 7604
13. 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide
14. Taselisib [usan:inn]
15. Unii-l08j2o299m
16. 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide
17. Taselisibgdc-0032
18. Taselisib (usan/inn)
19. Taselisib [usan]
20. Taselisib [who-dd]
21. Taselisib (gdc-0032)
22. Gtpl7794
23. Schembl1485247
24. Dtxsid00155842
25. Hms3674g19
26. Amy39941
27. Bcp09253
28. Ex-a1581
29. Bdbm50434806
30. Mfcd26142641
31. Nsc777425
32. Nsc800985
33. S7103
34. Zinc68267049
35. Akos026750303
36. Ccg-269338
37. Cs-1817
38. Db12108
39. Gdc-0032, Taselisib; Rg-7604
40. Nsc-777425
41. Nsc-800985
42. Sb16576
43. Ncgc00387039-02
44. 2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide
45. Ac-32794
46. As-10662
47. Bg166285
48. Hy-13898
49. D11774
50. J-690119
51. Q27088940
52. 1395408-87-3
53. 1h-pyrazole-1-acetamide, 4-(5,6-dihydro-2-(3-methyl-1-(1-methylethyl)-1h-1,2,4-triazol-5-yl)imidazo(1,2-d)(1,4)benzoxazepin-9-yl)-.alpha.,.alpha.-dimethyl-
54. 1h-pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1h-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-alpha,alpha-dimethyl-
55. 3-({[(3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic Aci D
56. 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1h-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-
57. A,
58. A-dimethyl-1h-pyrazole-1-acetamide
Molecular Weight | 460.5 g/mol |
---|---|
Molecular Formula | C24H28N8O2 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 460.23352217 g/mol |
Monoisotopic Mass | 460.23352217 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 751 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
65
PharmaCompass offers a list of Taselisib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Taselisib manufacturer or Taselisib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Taselisib manufacturer or Taselisib supplier.
PharmaCompass also assists you with knowing the Taselisib API Price utilized in the formulation of products. Taselisib API Price is not always fixed or binding as the Taselisib Price is obtained through a variety of data sources. The Taselisib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Taselisib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Taselisib, including repackagers and relabelers. The FDA regulates Taselisib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Taselisib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Taselisib supplier is an individual or a company that provides Taselisib active pharmaceutical ingredient (API) or Taselisib finished formulations upon request. The Taselisib suppliers may include Taselisib API manufacturers, exporters, distributors and traders.
Taselisib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Taselisib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Taselisib GMP manufacturer or Taselisib GMP API supplier for your needs.
A Taselisib CoA (Certificate of Analysis) is a formal document that attests to Taselisib's compliance with Taselisib specifications and serves as a tool for batch-level quality control.
Taselisib CoA mostly includes findings from lab analyses of a specific batch. For each Taselisib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Taselisib may be tested according to a variety of international standards, such as European Pharmacopoeia (Taselisib EP), Taselisib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Taselisib USP).